Uncategorized
Pipeline drugs target novel pathways to treat diabetic eye disease
BOSTON — Beyond anti-VEGFs, there are novel pharmacotherapies in development for the treatment of diabetic macular edema, one presenter here said.“We hope the combination of the current drugs as well as drugs in the pipeline … will help us to manage our patients with diabetic macular edema,” Quan Dong Nguyen, MD, said at Macula 2015.